This should have already started, “The pivotal phase 3 trial for emd-rx5 is expected to commence immediately following the successful completion of the phase 1 study currently in progress”, taken from the announcement in April. Fluff announcement, outlining already known details from previous announcements. From memory, the phase 3 trial was supposed to be done and dusted with results outlined by the end of the year, can’t see that happening if they’re only just recruiting now..
Ann: Emyria expands clinical sites for EMD-RX5 Phase 3 trial, page-3
Add to My Watchlist
What is My Watchlist?
